Ferroclix Syrup

Ferroclix

COMPOSITION:
Each 5 ml syrup contains:
Iron (III) hydroxide polymaltose complex
equivalent to elemental Iron 50 mg
Flavoured sugar free base q.s.

INDICATIONS:
Ferroclix Syrup is indicated for:

  • Treatment of latent Iron deficiency and Iron deficiency anemia including macrocytic anemia,
    nutritional anemia of infants, anemia due to excessive haemorrhage and anemia associated with infections and malignant diseases characterized by general weakness, dizziness, shortness of breath, weight loss, pale eyes, skin & nails.
  • Prevention and treatment of Iron deficiency anemia before, during and after pregnancy and during
    lactation.
  • Preventive treatment of anemia due to the Iron deficiency in the period of the intensive growth, adolescence, puberty, blood loss during menses, and to cover the recommended dietary allowance (RDA).

DESCRIPTION:
Ferroclix Syrup has been scientifically developed after years of research to provide adequate Iron.
It contains Iron (III) hydroxide polymaltose complex (IPC) which is a water soluble macromolecular complex of Polynuclear Iron (III) hydroxide and partially hydrolyzed dextrin (Polymaltose). The absorption of the ferric Iron from IPC is controlled by a feedback mechanism where IPC comes in contact with the Iron binding sites at the mucosal surface. Some physiological change occurs such that IPC releases the required amount of Ferric Iron which can be actively transported into the mucosal cell by a carrier protein and then released for binding to Ferritin or Transferrin. Iron is an essential constituent of the body necessary for haemoglobin formation and for process in living tissues involving oxygen. Iron is irregularly and incompletely absorbed from the gastrointestinal tract, the main sites of absorption being the duodenum and jejunum. Ferrous Iron passes through the gastrointestinal mucosa directly into the blood and is immediately bound to Transferrin. Transferrin transports Iron to the bone marrow where it is incorporated into haemoglobin. Most of the Iron liberated by destruction of haemoglobin is conserved and reused by the body. Iron excretion occurs primarily as desquamation of cells such as skin, GI mucosa, nails and hair; only trace amounts of Iron are excreted in the bile and sweat.

CONTRAINDICATIONS:
Ferroclix Syrup is contraindicated in patients with known hypersensitivity to any of the ingredients of the product.

SIDE EFFECTS:
Nausea, vomiting, gastric upset, dark stools. Symptoms of side effects, if any, should subside after discontinuing the medicine. If symptoms persist, please consult the physician.

DOSAGE:
Dosage and duration of therapy depends upon the extent of Iron deficiency or as directed by the physician.

Ferroclix Syrup 50 mg / 5 ml Manifested Iron
Deficiency
(daily dose)
Latent Iron
Deficiency
(daily dose)
Prevention of
anemia
(daily dose)
Pregnant Women 10 ml 2-3 times daily 10 ml once daily 5 ml 1-2 times daily
Adults and Children over 12 years and nursing women 10 ml 1-3 times daily 5 ml 1-2 times daily 5 ml once daily
Children (1-12 years) 5 ml 1-2 times daily 2.5 ml 1-2 times daily 2.5 ml once daily
Infants (upto 1 year) 2.5 ml 1-2 times daily

STORAGE:
Store in a cool, dark & dry place. Keep out of reach of children.

PRESENTATION:
200 ml Amber coloured PET bottle with measuring cup packed in a carton with insert.